Comparative Pharmacology
Head-to-head clinical analysis: DEXASPORIN versus PEDIAPRED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXASPORIN versus PEDIAPRED.
DEXASPORIN vs PEDIAPRED
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dexasporin is a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It binds to the glucocorticoid receptor, leading to modulation of gene expression and inhibition of pro-inflammatory mediators such as prostaglandins and leukotrienes.
Prednisolone is a glucocorticoid receptor agonist that binds to the intracellular glucocorticoid receptor, leading to modulation of gene expression. It suppresses inflammation by inhibiting phospholipase A2, reducing prostaglandin and leukotriene synthesis, and decreasing cytokine production (e.g., IL-1, IL-6, TNF-alpha). It also suppresses immune responses by reducing lymphocyte proliferation and activity.
1 to 2 mg/kg intramuscular or intravenous every 8 hours.
Oral: 5-60 mg/day as a single dose or divided doses; adjust based on condition and response.
None Documented
None Documented
3-4 hours (prolonged to 10-15 hours in renal impairment; monitor CrCl <30 mL/min)
2.5–3.5 hours (terminal) in children; clinical context: requires multiple daily doses for sustained effect.
Renal excretion (80-90% unchanged), biliary/fecal (10-20%)
Renal: ~80% as metabolites (mainly glucuronides and sulfates) and <5% unchanged; fecal: ~15%.
Category C
Category C
Corticosteroid/Antibiotic Combination
Corticosteroid